Taken together these results indicated that the inhibition of AURKA slowed cell division similarly in all four BC subtypes, suggesting that this hub gene could represent an important regulatory molecule that does not seem to suffer the effect of the pathology’s heterogeneity. Here, AURKA is linked to breast cancer.